Full Text
Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries

Abstract

Authors

V. Brodszky L. Gulacsi O. Balogh P Baji F. Rencz M. Péntek

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×